CFTR and cystic fibrosis: In support of the hypothesis that the HS-YFP test on PBMCs or monocytes from CF patients could be useful in evaluating treatment efficacy, we monitored CFTR activity before and during Ivacaftor therapy in a patient carrying CFTR G1349D and F508del mutations.